O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T17	B-Entity	14	16	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T17	I-Entity	16	17	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T17	I-Entity	17	22	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T17	I-Entity	23	24	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	25	33	activity	activity	I-NP	NN	O	2	PMOD	O
O	O	34	36	by	by	B-PP	IN	O	1	NMOD	O
T1	B-Protein	37	38	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T1	I-Protein	39	44	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	45	46	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	47	52	alpha	alpha	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	53	56	and	and	I-NP	CC	O	18	NMOD	O
T2	B-Protein	57	58	I	I	I-NP	NN	B-protein	17	NMOD	B-protein
T2	I-Protein	59	64	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T2	I-Protein	65	66	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
T2	I-Protein	67	71	beta	beta	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	72	81	stability	stability	I-NP	NN	O	8	PMOD	O
O	O	81	82	.	.	O	.	O	1	P	O

T18	B-Entity	84	97	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
T18	I-Entity	98	104	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T19	I-Entity	105	107	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T19	I-Entity	107	108	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T19	I-Entity	108	113	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T19	I-Entity	114	115	B	B	I-NP	NN	I-protein	7	SUB	I-protein
O	O	116	120	must	must	B-VP	MD	O	0	ROOT	O
O	O	121	123	be	be	I-VP	VB	O	7	VC	O
O	O	124	132	released	release	I-VP	VBN	O	8	VC	O
O	O	133	137	from	from	B-PP	IN	O	9	VMOD	O
O	O	138	149	cytoplasmic	cytoplasmic	B-NP	JJ	B-protein	13	NMOD	B-protein
O	O	150	160	inhibitory	inhibitory	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	161	170	molecules	molecule	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	171	172	(	(	O	(	O	18	DEP	O
O	O	172	173	I	I	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	174	179	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	180	182	Bs	B	I-NP	NNS	I-protein	18	DEP	I-protein
O	O	182	183	)	)	O	)	O	13	NMOD	O
O	O	184	186	in	in	B-SBAR	IN	O	7	VMOD	O
O	O	187	192	order	order	O	NN	O	19	DEP	O
O	O	193	195	to	to	B-VP	TO	O	22	VMOD	O
O	O	196	200	move	move	I-VP	VB	O	19	SBAR	O
O	O	201	203	to	to	B-PP	TO	O	22	VMOD	O
O	O	204	207	the	the	B-NP	DT	O	25	NMOD	O
O	O	208	215	nucleus	nucleus	I-NP	NN	O	23	PMOD	O
O	O	216	219	and	and	O	CC	O	22	VMOD	O
O	O	220	222	to	to	B-VP	TO	O	28	VMOD	O
O	O	223	231	activate	activate	I-VP	VB	O	22	VMOD	O
O	O	232	235	its	its	B-NP	PRP$	O	31	NMOD	O
T20	B-Entity	236	242	target	target	I-NP	NN	B-DNA	31	NMOD	B-DNA
T20	I-Entity	243	248	genes	gene	I-NP	NNS	I-DNA	28	OBJ	I-DNA
O	O	248	249	.	.	O	.	O	7	P	O

O	O	250	256	Little	Little	B-NP	JJ	O	2	SUB	O
O	O	257	259	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	260	265	known	know	I-VP	VBN	O	2	VC	O
O	O	266	271	about	about	B-PP	IN	O	3	VMOD	O
O	O	272	275	the	the	B-NP	DT	O	6	NMOD	O
O	O	276	286	mechanisms	mechanism	I-NP	NNS	O	4	PMOD	O
O	O	287	297	regulating	regulate	B-VP	VBG	O	6	NMOD	O
O	O	298	301	the	the	B-NP	DT	O	9	NMOD	O
O	O	302	313	maintenance	maintenance	I-NP	NN	O	7	OBJ	O
O	O	314	316	of	of	B-PP	IN	O	9	NMOD	O
O	O	317	329	constitutive	constitutive	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	330	337	nuclear	nuclear	I-NP	JJ	I-protein	16	NMOD	I-protein
T21	B-Entity	338	340	NF	NF	I-NP	NN	I-protein	16	NMOD	I-protein
T21	I-Entity	340	341	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T21	I-Entity	341	346	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T21	I-Entity	347	348	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	349	351	in	in	B-PP	IN	O	7	VMOD	O
O	O	352	356	some	some	B-NP	DT	O	21	NMOD	O
O	O	357	361	cell	cell	I-NP	NN	O	21	NMOD	O
O	O	361	362	-	-	O	HYPH	O	21	NMOD	O
O	O	362	367	types	type	B-NP	NNS	O	17	PMOD	O
O	O	368	371	and	and	B-PP	CC	O	17	PMOD	O
O	O	372	374	of	of	B-PP	IN	O	17	PMOD	O
O	O	375	384	sustained	sustained	B-NP	JJ	O	25	AMOD	O
O	O	385	392	nuclear	nuclear	I-NP	JJ	O	30	NMOD	O
T22	B-Entity	393	395	NF	NF	I-NP	NN	B-protein	30	NMOD	B-protein
T22	I-Entity	395	396	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T22	I-Entity	396	401	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T22	I-Entity	402	403	B	B	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	404	412	activity	activity	I-NP	NN	O	23	PMOD	O
O	O	413	418	after	after	B-PP	IN	O	30	NMOD	O
O	O	419	430	stimulation	stimulation	B-NP	NN	O	31	PMOD	O
O	O	430	431	.	.	O	.	O	2	P	O

O	O	432	441	Increased	Increase	B-NP	VBN	O	2	NMOD	O
O	O	442	450	turnover	turnover	I-NP	NN	O	3	SUB	O
O	O	451	454	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	455	459	been	be	I-VP	VBN	O	3	VC	O
O	O	460	470	implicated	implicate	I-VP	VBN	O	4	VC	O
O	O	471	473	in	in	B-PP	IN	O	5	VMOD	O
O	O	474	477	the	the	B-NP	DT	O	8	NMOD	O
O	O	478	488	regulation	regulation	I-NP	NN	O	6	PMOD	O
O	O	489	491	of	of	B-PP	IN	O	8	NMOD	O
O	O	492	504	constitutive	constitutive	B-NP	JJ	O	15	NMOD	O
T23	B-Entity	505	507	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T23	I-Entity	507	508	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T23	I-Entity	508	513	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T23	I-Entity	514	515	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	516	524	activity	activity	I-NP	NN	O	9	PMOD	O
O	O	525	527	in	in	B-PP	IN	O	15	NMOD	O
O	O	528	534	mature	mature	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	535	536	B	B	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	537	542	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	542	543	.	.	O	.	O	3	P	O

O	O	544	546	We	We	B-NP	PRP	O	3	SUB	O
O	O	547	556	therefore	therefore	B-ADVP	RB	O	3	VMOD	O
O	O	557	565	compared	compare	B-VP	VBD	O	0	ROOT	O
O	O	566	569	the	the	B-NP	DT	O	5	NMOD	O
O	O	570	578	turnover	turnover	I-NP	NN	O	3	OBJ	O
O	O	579	581	of	of	B-PP	IN	O	5	NMOD	O
T3	B-Protein	582	583	I	I	B-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	584	589	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T3	I-Protein	590	591	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
T3	I-Protein	592	597	alpha	alpha	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	598	601	and	and	I-NP	CC	O	15	NMOD	O
T4	B-Protein	602	603	I	I	I-NP	NN	B-protein	15	NMOD	B-protein
T4	I-Protein	604	609	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T4	I-Protein	610	611	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
T4	I-Protein	612	616	beta	beta	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	617	619	in	in	B-PP	IN	O	5	NMOD	O
O	O	620	626	mature	mature	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	627	628	B	B	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	629	634	cells	cell	I-NP	NNS	I-cell_type	22	NMOD	I-cell_type
O	O	635	638	and	and	O	CC	O	22	NMOD	O
O	O	639	643	HeLa	HeLa	B-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	644	649	cells	cell	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	649	650	.	.	O	.	O	3	P	O

O	O	651	655	Both	Both	B-NP	DT	O	2	NMOD	O
O	O	656	664	proteins	protein	I-NP	NNS	O	3	SUB	O
O	O	665	672	display	display	B-VP	VBP	O	0	ROOT	O
O	O	673	674	a	a	B-NP	DT	O	6	NMOD	O
O	O	675	679	high	high	I-NP	JJ	O	6	NMOD	O
O	O	680	688	turnover	turnover	I-NP	NN	O	3	OBJ	O
O	O	689	691	in	in	B-PP	IN	O	3	VMOD	O
O	O	692	693	B	B	B-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	694	699	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	700	708	although	although	B-SBAR	IN	O	3	VMOD	O
T5	B-Protein	709	710	I	I	B-NP	NN	B-protein	14	NMOD	B-protein
T5	I-Protein	711	716	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T5	I-Protein	717	718	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
T5	I-Protein	719	723	beta	beta	I-NP	NN	I-protein	15	SUB	I-protein
O	O	724	726	is	be	B-VP	VBZ	O	10	SBAR	O
O	O	727	739	considerably	considerably	B-ADJP	RB	O	15	PRD	O
O	O	740	744	more	more	I-ADJP	RBR	O	16	AMOD	O
O	O	745	751	stable	stable	I-ADJP	JJ	O	16	AMOD	O
O	O	752	756	than	than	B-PP	IN	O	16	AMOD	O
T6	B-Protein	757	758	I	I	B-NP	NN	B-protein	23	NMOD	B-protein
T6	I-Protein	759	764	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T6	I-Protein	765	766	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
T6	I-Protein	767	772	alpha	alpha	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	772	773	.	.	O	.	O	3	P	O

O	O	774	777	The	The	B-NP	DT	O	4	NMOD	O
O	O	778	782	half	half	I-NP	NN	O	4	NMOD	O
O	O	782	783	-	-	I-NP	HYPH	O	4	P	O
O	O	783	787	life	life	I-NP	NN	O	8	SUB	O
O	O	788	790	of	of	B-PP	IN	O	4	NMOD	O
O	O	791	795	both	both	B-NP	DT	O	7	NMOD	O
O	O	796	806	inhibitors	inhibitor	I-NP	NNS	O	5	PMOD	O
O	O	807	809	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	810	819	increased	increase	I-VP	VBN	O	8	VC	O
O	O	820	822	in	in	B-PP	IN	O	9	VMOD	O
O	O	823	827	HeLa	HeLa	B-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	828	833	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	833	834	.	.	O	.	O	8	P	O

O	O	835	837	In	In	B-PP	IN	O	16	VMOD	O
O	O	838	846	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	846	847	,	,	O	,	O	16	P	O
O	O	848	851	all	all	B-NP	DT	O	5	NMOD	O
O	O	852	857	other	other	I-NP	JJ	O	16	SUB	O
T24	B-Entity	858	860	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T24	I-Entity	860	861	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T24	I-Entity	861	866	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T24	I-Entity	867	868	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
T24	I-Entity	868	869	/	/	B-NP	SYM	O	14	NMOD	O
T24	I-Entity	869	870	I	I	I-NP	NN	B-protein	14	NMOD	B-protein
T24	I-Entity	871	876	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T24	I-Entity	877	878	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	879	888	molecules	molecule	I-NP	NNS	I-protein	5	NMOD	I-protein
O	O	889	895	tested	test	B-VP	VBN	O	5	NMOD	O
O	O	896	899	are	be	B-VP	VBP	O	0	ROOT	O
O	O	900	910	relatively	relatively	B-ADJP	RB	O	18	AMOD	O
O	O	911	917	stable	stable	I-ADJP	JJ	O	16	PRD	O
O	O	918	920	in	in	B-PP	IN	O	18	AMOD	O
O	O	921	925	both	both	O	CC	O	23	NMOD	O
O	O	926	930	cell	cell	B-ADJP	NN	O	23	NMOD	O
O	O	930	931	-	-	I-ADJP	HYPH	O	23	P	O
O	O	931	936	types	type	B-NP	NNS	O	19	PMOD	O
O	O	936	937	.	.	O	.	O	16	P	O

O	O	938	941	The	The	B-NP	DT	O	3	NMOD	O
O	O	942	950	elevated	elevated	I-NP	JJ	O	3	NMOD	O
O	O	951	959	turnover	turnover	I-NP	NN	O	13	SUB	O
O	O	960	962	of	of	B-PP	IN	O	3	NMOD	O
O	O	963	973	endogenous	endogenous	B-NP	JJ	O	4	PMOD	O
T7	B-Protein	974	975	I	I	I-NP	NN	B-protein	9	NMOD	B-protein
T7	I-Protein	976	981	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T7	I-Protein	982	983	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
T7	I-Protein	984	989	alpha	alpha	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	990	992	in	in	B-PP	IN	O	3	NMOD	O
O	O	993	1000	Namalwa	Namalwa	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	1001	1006	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	1007	1009	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1010	1019	inhibited	inhibit	I-VP	VBN	O	13	VC	O
O	O	1020	1022	by	by	B-PP	IN	O	14	VMOD	O
O	O	1023	1024	a	a	B-NP	DT	O	18	NMOD	O
O	O	1025	1035	proteasome	proteasome	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	1036	1045	inhibitor	inhibitor	I-NP	NN	O	15	PMOD	O
O	O	1046	1049	and	and	O	CC	O	13	VMOD	O
O	O	1050	1054	thus	thus	B-VP	RB	O	13	VMOD	O
O	O	1055	1060	seems	seem	I-VP	VBZ	O	13	VMOD	O
O	O	1061	1063	to	to	I-VP	TO	O	23	VMOD	O
O	O	1064	1066	be	be	I-VP	VB	O	21	VMOD	O
O	O	1067	1073	driven	drive	I-VP	VBN	O	23	VC	O
O	O	1074	1076	by	by	B-PP	IN	O	24	VMOD	O
O	O	1077	1080	the	the	B-NP	DT	O	29	NMOD	O
O	O	1081	1085	same	same	I-NP	JJ	O	29	NMOD	O
O	O	1086	1097	degradation	degradation	I-NP	NN	O	29	NMOD	O
O	O	1098	1107	machinery	machinery	I-NP	NN	O	25	PMOD	O
O	O	1108	1110	as	as	B-PP	IN	O	29	NMOD	O
O	O	1111	1114	the	the	B-NP	DT	O	33	NMOD	O
O	O	1115	1121	slower	slow	I-NP	JJR	O	33	NMOD	O
O	O	1122	1130	turnover	turnover	I-NP	NN	O	30	PMOD	O
O	O	1131	1133	in	in	B-PP	IN	O	33	NMOD	O
O	O	1134	1137	non	non	B-NP	AFX	O	38	NMOD	O
O	O	1137	1138	-	-	I-NP	HYPH	B-cell_type	38	NMOD	B-cell_type
O	O	1138	1139	B	B	I-NP	NN	I-cell_type	38	NMOD	I-cell_type
O	O	1140	1145	cells	cell	I-NP	NNS	I-cell_type	34	PMOD	I-cell_type
O	O	1145	1146	.	.	O	.	O	13	P	O

O	O	1147	1158	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	1158	1159	,	,	O	,	O	4	P	O
O	O	1160	1162	we	we	B-NP	PRP	O	4	SUB	O
O	O	1163	1175	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	1176	1179	the	the	B-NP	DT	O	6	NMOD	O
O	O	1180	1189	processes	process	I-NP	NNS	O	4	OBJ	O
O	O	1190	1198	involved	involve	B-VP	VBN	O	6	NMOD	O
O	O	1199	1201	in	in	B-PP	IN	O	7	VMOD	O
O	O	1202	1212	persistent	persistent	B-NP	JJ	O	10	NMOD	O
O	O	1213	1223	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	1224	1226	of	of	B-PP	IN	O	10	NMOD	O
T26	B-Entity	1227	1229	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T26	I-Entity	1229	1230	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T26	I-Entity	1230	1235	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T26	I-Entity	1236	1237	B	B	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	1237	1238	.	.	O	.	O	4	P	O

T8	B-Protein	1239	1242	TNF	TNF	B-NP	NN	B-protein	4	NMOD	B-protein
T8	I-Protein	1242	1243	-	-	I-NP	HYPH	O	4	NMOD	O
T8	I-Protein	1243	1248	alpha	alpha	I-NP	NN	O	4	NMOD	O
O	O	1249	1258	signaling	signaling	I-NP	NN	O	5	SUB	O
O	O	1259	1264	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	1265	1267	to	to	B-PP	TO	O	5	VMOD	O
O	O	1268	1269	a	a	B-NP	DT	O	9	NMOD	O
O	O	1270	1275	rapid	rapid	I-NP	JJ	O	9	NMOD	O
O	O	1276	1285	depletion	depletion	I-NP	NN	O	6	PMOD	O
O	O	1286	1288	of	of	B-PP	IN	O	9	NMOD	O
O	O	1289	1297	cellular	cellular	B-NP	JJ	O	16	NMOD	O
T9	B-Protein	1298	1299	I	I	I-NP	NN	B-protein	15	NMOD	B-protein
T9	I-Protein	1300	1305	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T9	I-Protein	1306	1307	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
T9	I-Protein	1308	1312	beta	beta	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	1313	1318	pools	pool	I-NP	NNS	O	10	PMOD	O
O	O	1318	1319	.	.	O	.	O	5	P	O

T10	B-Protein	1320	1321	I	I	B-NP	NN	B-protein	4	NMOD	B-protein
T10	I-Protein	1322	1327	kappa	kappa	I-NP	NN	I-protein	4	NMOD	I-protein
T10	I-Protein	1328	1329	B	B	I-NP	NN	I-protein	4	NMOD	I-protein
T10	I-Protein	1330	1335	alpha	alpha	I-NP	NN	I-protein	5	SUB	I-protein
O	O	1336	1338	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1339	1350	efficiently	efficiently	I-VP	RB	O	5	VMOD	O
O	O	1351	1364	resynthesized	resynthesize	I-VP	VBN	O	5	VC	O
O	O	1365	1372	whereas	whereas	B-PP	IN	O	5	VMOD	O
T11	B-Protein	1373	1374	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T11	I-Protein	1375	1380	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T11	I-Protein	1381	1382	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T11	I-Protein	1383	1387	beta	beta	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	1388	1394	levels	level	I-NP	NNS	O	14	SUB	O
O	O	1395	1399	stay	stay	B-VP	VBP	O	8	SBAR	O
O	O	1400	1403	low	low	B-ADJP	JJ	O	14	PRD	O
O	O	1404	1407	for	for	B-PP	IN	O	15	AMOD	O
O	O	1408	1409	a	a	B-NP	DT	O	19	NMOD	O
O	O	1410	1419	prolonged	prolong	I-NP	VBN	O	19	NMOD	O
O	O	1420	1424	time	time	I-NP	NN	O	16	PMOD	O
O	O	1424	1425	.	.	O	.	O	5	P	O

T27	B-Entity	1426	1428	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T27	I-Entity	1428	1429	-	-	I-NP	HYPH	I-protein	6	NMOD	I-protein
T27	I-Entity	1429	1434	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T27	I-Entity	1435	1436	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	1437	1444	binding	binding	I-NP	NN	O	6	NMOD	O
O	O	1445	1453	activity	activity	I-NP	NN	O	7	SUB	O
O	O	1454	1457	can	can	B-VP	MD	O	0	ROOT	O
O	O	1458	1460	be	be	I-VP	VB	O	7	VC	O
O	O	1461	1469	detected	detect	I-VP	VBN	O	8	VC	O
O	O	1470	1473	for	for	B-PP	IN	O	9	VMOD	O
O	O	1474	1481	several	several	B-NP	JJ	O	12	NMOD	O
O	O	1482	1487	hours	hour	I-NP	NNS	O	10	PMOD	O
O	O	1488	1493	after	after	B-PP	IN	O	12	NMOD	O
O	O	1494	1505	stimulation	stimulation	B-NP	NN	O	13	PMOD	O
O	O	1505	1506	.	.	O	.	O	7	P	O

O	O	1507	1509	We	We	B-NP	PRP	O	2	SUB	O
O	O	1510	1515	found	find	B-VP	VBD	O	0	ROOT	O
O	O	1516	1520	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	1521	1528	removal	removal	B-NP	NN	O	12	SUB	O
O	O	1529	1531	of	of	B-PP	IN	O	4	NMOD	O
O	O	1532	1535	the	the	B-NP	DT	O	11	NMOD	O
T12	B-Protein	1536	1539	TNF	TNF	I-NP	NN	B-protein	9	NMOD	B-protein
T12	I-Protein	1539	1540	-	-	O	HYPH	O	9	P	O
T12	I-Protein	1540	1545	alpha	alpha	B-NP	SYM	O	11	NMOD	O
O	O	1546	1556	containing	contain	B-VP	VBG	O	11	NMOD	O
O	O	1557	1563	medium	medium	B-NP	NN	O	5	PMOD	O
O	O	1564	1570	causes	cause	B-VP	VBZ	O	3	SBAR	O
O	O	1571	1572	a	a	B-NP	DT	O	15	NMOD	O
O	O	1573	1578	rapid	rapid	I-NP	JJ	O	15	NMOD	O
O	O	1579	1587	decrease	decrease	I-NP	NN	O	12	OBJ	O
O	O	1588	1590	in	in	B-PP	IN	O	15	NMOD	O
O	O	1591	1598	nuclear	nuclear	B-NP	JJ	B-protein	21	NMOD	B-protein
T28	B-Entity	1599	1601	NF	NF	I-NP	NN	I-protein	21	NMOD	I-protein
T28	I-Entity	1601	1602	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T28	I-Entity	1602	1607	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T28	I-Entity	1608	1609	B	B	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	1609	1610	.	.	O	.	O	2	P	O

O	O	1611	1612	A	A	B-NP	DT	O	2	NMOD	O
O	O	1613	1624	phosphoform	phosphoform	I-NP	NN	O	10	SUB	O
O	O	1625	1627	of	of	B-PP	IN	O	2	NMOD	O
O	O	1628	1633	newly	newly	B-NP	RB	O	5	AMOD	O
O	O	1634	1645	synthesized	synthesize	I-NP	VBN	O	9	NMOD	O
T13	B-Protein	1646	1647	I	I	I-NP	NN	B-protein	9	NMOD	B-protein
T13	I-Protein	1648	1653	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Protein	1654	1655	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Protein	1656	1661	alpha	alpha	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	1662	1664	is	be	B-VP	VBZ	O	25	VMOD	O
O	O	1665	1672	visible	visible	B-ADJP	JJ	O	10	PRD	O
O	O	1673	1677	when	when	B-ADVP	WRB	O	10	VMOD	O
O	O	1678	1689	degradation	degradation	B-NP	NN	O	17	SUB	O
O	O	1690	1692	by	by	B-PP	IN	O	13	NMOD	O
O	O	1693	1696	the	the	B-NP	DT	O	16	NMOD	O
T29	B-Entity	1697	1707	proteasome	proteasome	I-NP	NN	B-protein	14	PMOD	B-protein
O	O	1708	1710	is	be	B-VP	VBZ	O	12	SBAR	O
O	O	1711	1720	inhibited	inhibit	I-VP	VBN	O	17	VC	O
O	O	1721	1724	and	and	O	CC	O	25	VMOD	O
O	O	1725	1728	new	new	B-NP	JJ	O	25	SUB	O
T14	B-Protein	1729	1730	I	I	I-NP	NN	B-protein	24	NMOD	B-protein
T14	I-Protein	1731	1736	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T14	I-Protein	1737	1738	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T14	I-Protein	1739	1744	alpha	alpha	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	1745	1753	displays	display	B-VP	VBZ	O	0	ROOT	O
O	O	1754	1757	the	the	B-NP	DT	O	28	NMOD	O
O	O	1758	1762	same	same	I-NP	JJ	O	28	NMOD	O
O	O	1763	1773	properties	property	I-NP	NNS	O	25	OBJ	O
O	O	1774	1783	regarding	regard	B-VP	VBG	O	28	NMOD	O
O	O	1784	1799	phosphorylation	phosphorylation	B-NP	NN	O	32	NMOD	O
O	O	1800	1803	and	and	I-NP	CC	O	32	NMOD	O
O	O	1804	1815	degradation	degradation	I-NP	NN	O	29	PMOD	O
O	O	1816	1818	in	in	B-PP	IN	O	32	NMOD	O
O	O	1819	1827	response	response	B-NP	NN	O	33	PMOD	O
O	O	1828	1830	to	to	B-PP	TO	O	34	NMOD	O
O	O	1831	1832	a	a	B-NP	DT	O	38	NMOD	O
O	O	1833	1839	second	second	I-NP	JJ	O	38	NMOD	O
O	O	1840	1847	inducer	inducer	I-NP	NN	O	35	PMOD	O
O	O	1847	1848	.	.	O	.	O	25	P	O

O	O	1849	1854	There	There	B-NP	EX	O	2	SUB	O
O	O	1855	1857	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1858	1860	no	no	B-NP	DT	O	5	NMOD	O
O	O	1861	1872	significant	significant	I-NP	JJ	O	5	NMOD	O
O	O	1873	1883	difference	difference	I-NP	NN	O	2	PRD	O
O	O	1884	1886	in	in	B-PP	IN	O	5	NMOD	O
O	O	1887	1890	the	the	B-NP	DT	O	8	NMOD	O
O	O	1891	1899	turnover	turnover	I-NP	NN	O	6	PMOD	O
O	O	1900	1902	of	of	B-PP	IN	O	8	NMOD	O
O	O	1903	1906	pre	pre	B-NP	AFX	B-DNA	19	NMOD	B-DNA
O	O	1906	1907	-	-	I-NP	HYPH	O	10	P	O
O	O	1908	1911	and	and	I-NP	CC	O	19	NMOD	O
O	O	1912	1916	post	post	I-NP	AFX	O	19	NMOD	O
O	O	1916	1917	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	1917	1926	inductive	inductive	I-NP	JJ	O	19	NMOD	O
T15	B-Protein	1927	1928	I	I	I-NP	NN	B-protein	19	NMOD	B-protein
T15	I-Protein	1929	1934	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T15	I-Protein	1935	1936	B	B	I-NP	NN	I-protein	19	NMOD	I-protein
T15	I-Protein	1937	1942	alpha	alpha	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1942	1943	.	.	O	.	O	2	P	O

O	O	1944	1949	These	These	B-NP	DT	O	2	NMOD	O
O	O	1950	1962	observations	observation	I-NP	NNS	O	3	SUB	O
O	O	1963	1970	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1971	1975	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1976	1987	resynthesis	resynthesis	B-NP	NN	O	12	NMOD	O
O	O	1988	1990	of	of	B-PP	IN	O	5	NMOD	O
T16	B-Protein	1991	1992	I	I	B-NP	NN	B-protein	10	NMOD	B-protein
T16	I-Protein	1993	1998	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T16	I-Protein	1999	2000	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
T16	I-Protein	2001	2006	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	2007	2010	and	and	O	CC	O	12	NMOD	O
O	O	2011	2018	removal	removal	B-NP	NN	O	16	SUB	O
O	O	2019	2021	of	of	B-PP	IN	O	12	NMOD	O
O	O	2022	2025	the	the	B-NP	DT	O	15	NMOD	O
O	O	2026	2034	stimulus	stimulus	I-NP	NN	O	13	PMOD	O
O	O	2035	2038	are	be	B-VP	VBP	O	4	SBAR	O
O	O	2039	2049	obligatory	obligatory	B-NP	JJ	O	18	NMOD	O
O	O	2050	2055	steps	step	I-NP	NNS	O	16	PRD	O
O	O	2056	2059	for	for	B-PP	IN	O	18	NMOD	O
O	O	2060	2063	the	the	B-NP	DT	O	21	NMOD	O
O	O	2064	2076	inactivation	inactivation	I-NP	NN	O	19	PMOD	O
O	O	2077	2079	of	of	B-PP	IN	O	21	NMOD	O
O	O	2080	2087	nuclear	nuclear	B-NP	JJ	B-protein	26	NMOD	B-protein
T30	B-Entity	2088	2090	NF	NF	I-NP	NN	I-protein	26	NMOD	I-protein
T30	I-Entity	2091	2096	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T30	I-Entity	2097	2098	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	2098	2099	.	.	O	.	O	3	P	O
